{"filing":{"accession_number":"0001493152-26-041978","cik":"0001506983","ticker":"GCTK","company_name":"Glucotrack, Inc.","form":"8-K","filing_date":"2026-09-09","report_date":"2026-09-04","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226041978/form8-k.htm"},"events":[{"id":32412,"run_id":29777,"accession_number":"0001493152-26-041978","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"Glucotrack entered into a Settlement Agreement on September 4, 2026 creating new direct financial obligations: an initial $2.0 million payment, a $2.0 million convertible promissory note payable in quarterly installments from November 2026 through August 2027 at 5% interest, and up to $125,000 in legal fees. The convertible note with embedded equity conversion rights and acceleration provisions upon default constitutes a material debt issuance.","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-09-09","form":"8-K","submitted_at":null,"items":[{"id":35578,"accession_number":"0001493152-26-041978","item_number":"1.01","item_title":"Entry Into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Glucotrack entered into a Settlement Agreement on September 4, 2026 that creates new direct financial obligations: an initial $2.0 million payment, a $2.0 million convertible promissory note payable in quarterly installments from November 2026 through August 2027 at 5% interest, and up to $125,000 in legal fees. While the settlement resolves a dispute over prior indebtedness owed by a related entity (Apimeds), the material event disclosed here is the creation of the convertible note and payment obligations by Glucotrack itself, which constitutes a debt issuance under Item 1.01. The convertible feature and acceleration provisions upon default are typical debt terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T21:01:00.403342+00:00","company_name":"","ticker":null,"filing_date":""},{"id":35579,"accession_number":"0001493152-26-041978","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 2.03 is filed and incorporates Item 1.01 by reference, indicating creation of a direct financial obligation. While the specific details are not provided in this excerpt, Item 2.03 filings typically disclose debt issuances, credit facilities, or other financial obligations. The incorporation of Item 1.01 (which commonly covers M\u0026A or material agreements) suggests a debt-related transaction. Debt issuances are material to investors assessing the registrant's capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T21:01:00.403342+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":32413,"run_id":29777,"accession_number":"0001493152-26-041978","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Glucotrack issued shares of common stock issuable upon conversion of the convertible promissory note in an unregistered private placement under Section 4(a)(2) of the Securities Act. The conversion feature embedded in the debt instrument creates a dilutive equity issuance structure typical of convertible debt financing.","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-09-09","form":"8-K","submitted_at":null,"items":[{"id":35580,"accession_number":"0001493152-26-041978","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities under Section 4(a)(2) of the Securities Act. The filing references a convertible note (the \"Note\") with shares of common stock issuable upon conversion, issued in reliance on the private placement exemption. This is a classic dilutive issuance structure typical of PIPE or convertible debt financing at smaller-cap companies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T21:01:00.403342+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35578,"accession_number":"0001493152-26-041978","item_number":"1.01","item_title":"Entry Into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Glucotrack entered into a Settlement Agreement on September 4, 2026 that creates new direct financial obligations: an initial $2.0 million payment, a $2.0 million convertible promissory note payable in quarterly installments from November 2026 through August 2027 at 5% interest, and up to $125,000 in legal fees. While the settlement resolves a dispute over prior indebtedness owed by a related entity (Apimeds), the material event disclosed here is the creation of the convertible note and payment obligations by Glucotrack itself, which constitutes a debt issuance under Item 1.01. The convertible feature and acceleration provisions upon default are typical debt terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T21:01:00.403342+00:00","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-09-09"},{"id":35579,"accession_number":"0001493152-26-041978","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 2.03 is filed and incorporates Item 1.01 by reference, indicating creation of a direct financial obligation. While the specific details are not provided in this excerpt, Item 2.03 filings typically disclose debt issuances, credit facilities, or other financial obligations. The incorporation of Item 1.01 (which commonly covers M\u0026A or material agreements) suggests a debt-related transaction. Debt issuances are material to investors assessing the registrant's capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T21:01:00.403342+00:00","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-09-09"},{"id":35580,"accession_number":"0001493152-26-041978","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities under Section 4(a)(2) of the Securities Act. The filing references a convertible note (the \"Note\") with shares of common stock issuable upon conversion, issued in reliance on the private placement exemption. This is a classic dilutive issuance structure typical of PIPE or convertible debt financing at smaller-cap companies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T21:01:00.403342+00:00","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-09-09"}]}